ASA claims that BevMD used its name and trademarks without permission and made multiple false and misleading statements about the ASA, including false claims that ASA had approved and endorsed BevMD’s Clearfast product.
As a nonprofit association, the society does not test, endorse or approve medical products, said ASA CEO Paul Pomerantz.
The suit has been filed in the United States District Court for the Northern District of Illinois, Eastern Division.
More articles on anesthesia:
University of Florida College of Medicine names Dr. Timothy Morey chair
MEDNAX acquires MEMAC Associates
Dr. Jean-François Pittet to serve as next editor-in-chief of Anesthesia & Analgesia
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
